Yu, J., Petrie, I. D., Levy, R. H., & Ragueneau-Majlessi, I. (2019). Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017. Drug metabolism and disposition, 47(2), 135-144. https://doi.org/10.1124/dmd.118.084905
Chicago Style (17th ed.) CitationYu, Jingjing, Ichiko D. Petrie, René H. Levy, and Isabelle Ragueneau-Majlessi. "Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017." Drug Metabolism and Disposition 47, no. 2 (2019): 135-144. https://doi.org/10.1124/dmd.118.084905.
MLA (9th ed.) CitationYu, Jingjing, et al. "Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017." Drug Metabolism and Disposition, vol. 47, no. 2, 2019, pp. 135-144, https://doi.org/10.1124/dmd.118.084905.